Trends in Contraceptive Use Among Women With Human Immunodeficiency Virus
Authors:
- Mengyang SunMSMengyang Sun
- Gypsyamber DʼsouzaGDGypsyamber Dʼsouza
- L. Stewart MassadLML. Stewart Massad
- 1 October 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 120 (4) , 783-790
Abstract
OBJECTIVE: To estimate trends in contraceptive use, especially long-acting reversible contraceptives (LARCs) and condoms, among human immunodeficiency virus (HIV)-seropositive and HIV-seronegative women. METHODS: Human immunodeficiency virus–seropositive and HIV-seronegative women in a multicenter longitudinal cohort were interviewed semiannually between 1998 and 2010 about sexual behaviors and contraceptive use. Trends in contraceptive use by women aged 18–45 years who were at risk for unintended pregnancy but not trying to conceive were analyzed using generalized estimating equations. RESULTS: Condoms were the dominant form of contraception for HIV-seropositive women and showed little change across time. Less than 15% of these women used no contraception. Between 1998 and 2010, LARC use increased among HIV-seronegative women from 4.8% (6 of 126) to 13.5% (19 of 141, P=.02), but not significantly among seropositive women (0.9% [4 of 438] to 2.8% [6 of 213], P=.09). Use of highly effective contraceptives, including pills, patches, rings, injectable progestin, implants, and intrauterine devices, ranged from 15.2% (53 of 348) in 1998 to 17.4% (37 of 213) in 2010 (P=.55). Human immunodeficiency virus–seronegative but not HIV-seropositive LARC users were less likely than nonusers to use condoms consistently (hazard ratio 0.51, 95% confidence interval [CI] 0.32–0.81, P=.004 for seronegative women; hazard ratio 1.09, 95% CI 0.96–1.23 for seropositive women). CONCLUSION: Although most HIV-seropositive women use contraception, they rely primarily on condoms and have not experienced the increase in LARC use seen among seronegative women. Strategies to improve simultaneous use of condoms and LARC are needed to minimize risk of unintended pregnancy as well as HIV transmission and acquisition of sexually transmitted infections. LEVEL OF EVIDENCE: IIKeywords
This publication has 27 references indexed in Scilit:
- Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort studyThe Lancet Infectious Diseases, 2012
- Race, Ethnicity and Differences in Contraception Among Low‐Income Women: Methods Received By Family PACT Clients, California, 2001–2007Perspectives on Sexual and Reproductive Health, 2011
- Continuation and Satisfaction of Reversible ContraceptionObstetrics & Gynecology, 2011
- Intrauterine contraception in Saint Louis: a survey of obstetrician and gynecologists' knowledge and attitudesContraception, 2010
- Sex Steroid Hormones, Hormonal Contraception, and the Immunobiology of Human Immunodeficiency Virus-1 InfectionEndocrine Reviews, 2009
- Determinants of contraceptive choice among women with HIVAIDS, 2009
- A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virusAmerican Journal of Obstetrics and Gynecology, 2007
- Is the intrauterine device appropriate contraception for HIV-1-infected women?BJOG: An International Journal of Obstetrics & Gynaecology, 2001
- Factors associated with pregnancy and pregnancy resolution in HIV seropositive womenSocial Science & Medicine, 1995
- The Impact of Knowledge of Human Immunodeficiency Virus Serostatus on Contraceptive Choice and Repeat PregnancyObstetrics & Gynecology, 1995